CINECA IRIS Institutional Research Information System

Multicenter phase II study of whole-body and intracranial activity with ceritinib in patients with ALK-rearranged non-small-cell lung cancer previously treated with chemotherapy and crizotinib: Results from ASCEND-2

SCAGLIOTTI, Giorgio Vittorio;
2016-01-01
2016
34
24
2866
2873
http://jco.ascopubs.org/content/34/24/2866.full.pdf
Oncology; Cancer Research
Crinò, Lucio; Ahn, Myung-Ju; De Marinis, Filippo; Groen, Harry J. M.; Wakelee, Heather; Hida, Toyoaki; Mok, Tony; Spigel, David; Felip, Enriqueta; Nishio, Makoto; Scagliotti, Giorgio; Branle, Fabrice; Emeremni, Chetachi; Quadrigli, Massimiliano; Zhang, Jie; Shaw, Alice T.
03A-Articolo su Rivista
File in questo prodotto:
File Dimensione Formato  
Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients WithALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib_ Results From ASCEND-2.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 968.12 kB
Formato Adobe PDF
Visualizza/Apri
968.12 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1623631
Citazioni
  • ???jsp.display-item.citation.pmc??? 135
  • Scopus 318
  • ???jsp.display-item.citation.isi??? 275
social impact